INTERNATIONAL PATENT: ORIC PHARMACEUTICALS, INC. FILES APPLICATION FOR "PRC2 INHIBITORS FOR USE IN TREATING SICKLE CELL DISEASE"

GENEVA, March 4 -- ORIC PHARMACEUTICALS, INC. (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2024/043672) for "PRC2 INHIBITORS FOR USE IN TREATING SICKLE CELL DISEASE" on Aug 23, 2024. With publication no. WO/2025/043191, the details related to the patent application was published on Feb 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FRIEDMAN, Lori S. (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080), MULTANI, Pratik Sharad (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080), MANEVAL, Edna Cho...